Shuichi Takishita
Overview
Explore the profile of Shuichi Takishita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazato M, Nakamoto M, Sakima A, Yamazato Y, Takishita S, Ohya Y
Clin Exp Hypertens
. 2018 May;
41(3):255-262.
PMID: 29764227
Stimulation of α2-adrenoceptor/I1-imidazoline receptors in the rostral ventrolateral medulla decreases the blood pressure via sympathoinhibition. However, alteration of receptor responses in genetically hypertensive rats remains unclear. We examined cardiovascular responses...
2.
Kita T, Sakima A, Yokota N, Tamaki N, Etoh T, Shimokubo T, et al.
Clin Exp Hypertens
. 2015 May;
37(7):574-9.
PMID: 25992487
Blood pressure (BP) control throughout the entire day is recommended for cardiovascular protection. Angiotensin-II receptor blockers (ARBs) are widely used in hypertensive patients because of beneficial class effects. It is...
3.
Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, et al.
J Hypertens
. 2014 Jul;
32(10):2054-63.
PMID: 24999799
Objective: The aim of the present study was to compare the cardiovascular effects of olmesartan, an angiotensin II receptor blocker, combined with a calcium channel blocker (CCB) or a diuretic,...
4.
Sakima A, Kita T, Nakada S, Yokota N, Tamaki N, Etoh T, et al.
Clin Exp Hypertens
. 2013 May;
36(1):40-5.
PMID: 23713902
Abstract Although blockade of the renin-angiotensin system by increasing the dose of angiotensin II receptor blockers (ARBs) is recommended to achieve clinical benefits in terms of blood pressure (BP) control...
5.
Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al.
Hypertension
. 2010 Jun;
56(2):196-202.
PMID: 20530299
In this prospective, randomized, open-label, blinded end point study, we aimed to establish whether strict blood pressure control (<140 mm Hg) is superior to moderate blood pressure control (> or...
6.
Toma Y, Ishiki T, Nagahama K, Okumura K, Kamiyama T, Kohagura K, et al.
Intern Med
. 2009 Sep;
48(18):1667-9.
PMID: 19755771
Irritable urological symptoms with gross hematuria and bilateral lumbar pain developed when the patient received penicillin G for endocarditis. These symptoms were followed by renal insufficiency. A contrast-enhanced abdominal computed...
7.
Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S
Hypertens Res
. 2009 Aug;
32(9):801-6.
PMID: 19644506
High heart rate and metabolic syndrome are risk factors for cardiovascular morbidity and mortality. The relationship between heart rate and risk of developing metabolic syndrome has not been studied in...
8.
Kohagura K, Tomiyama N, Kinjo K, Takishita S, Iseki K
Clin Exp Nephrol
. 2009 Jun;
13(6):614-20.
PMID: 19526304
Background: The prevalence of chronic kidney disease (CKD) is high in developed countries, including Japan. However, little is known about the prevalence of anemia according to the estimated glomerular filtration...
9.
Kakihana A, Ishida A, Miyagi M, Ishiki T, Okumura K, Kamiyama T, et al.
Intern Med
. 2009 Jun;
48(12):1003-7.
PMID: 19525588
Cardiac involvement is a rare complication with thromboangiitis obliterans (TAO). We report a 29-year-old man with TAO accompanied with non-ischemic dilated cardiomyopathy. He had no history of heart disease, but...
10.
Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S
Clin Exp Nephrol
. 2009 May;
13(5):487-493.
PMID: 19444548
Background: High heart rate and chronic kidney disease (CKD) are both risk factors for cardiovascular morbidity and mortality. The relationship between heart rate and the risk of developing CKD, however,...